According to GlobalData’s medical device pipeline database, 160 Mechanical Circulatory Support Devices devices are in various stages of development globally. GlobalData’s report Mechanical Circulatory Support Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 80 are in active development, while the remaining 85 are in an inactive stage of development. There are 47 products in the early stages of development, and the remaining 33 are in the late stages of development.
Mechanical Circulatory Support Devices are devices which replace or assist the pumping function of the ventricles. Mechanical Circulatory Support Devices support the functioning of a weak heart by pumping blood. They can be used as a bridge to transplantation, for destination therapy, or as a bridge to recovery postcardiotomy. External/Paracorporeal Ventricular Assist Devices, Left Ventricular Assist Devices and Total Artificial Heart are tracked in this segment. Extracorporeal membrane oxygenators and percutaneous devices are not covered here. One unit refers to One mechanical circulatory support device.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Mechanical Circulatory Support Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Mechanical Circulatory Support Devices devices. Overall, most of these Mechanical Circulatory Support Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Mechanical Circulatory Support Devices include HeartWare International, CorInnova, Abiomed, Syncardia Systems, Shanghai Xinhengrui Medical Technology, Perfusion Solution, ReliantHeart, Jarvik Heart, Calon Cardio-Technology and Thoratec.
For a complete picture of the developmental pipeline for Mechanical Circulatory Support Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.